力生制药：高级管理人员郭晓燕计划减持公司股份不超过约1.12万股

Group 1 - Company Lifesun Pharmaceutical (SZ 002393) announced that senior management personnel Guo Xiaoyan plans to reduce her holdings by no more than approximately 11,200 shares within three months after 15 trading days from the announcement date, representing a maximum reduction of 0.0044% of the total share capital excluding shares in the repurchase account [1] - As of the report date, Lifesun Pharmaceutical's market capitalization is 5.4 billion yuan [1] - For the first half of 2025, the revenue composition of Lifesun Pharmaceutical is 100% from the pharmaceutical industry [1]